The Impact of Telehealth on Buprenorphine Prescribing at a Large Federally Qualified Health Center During COVID-19
During the first year of COVID, telehealth was associated with increased likelihood that patients received buprenorphine; those who had telehealth remained in buprenorphine care longer compared to those who only had office-based visits. Increasing buprenorphine access through telehealth can play a significant role in retention in care for OUD.
Authors
- Eve Walter (ORCID: https://orcid.org/0000-0001-6766-9575)
- Ann Winters (ORCID: https://orcid.org/0000-0003-3594-6886)
Institutions
- Mount Sinai Hospital (US)
Publication Details
- Journal
- Journal of Addiction Medicine
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1097/adm.0000000000001397
- Citations
- 1
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.54